 |
|
Early Electrodiagnostic Findings in Guillain-Barré Syndrome
Paul H. Gordon, MD;
Asa J. Wilbourn, MD
Arch Neurol. 2001;58:913-917.
ABSTRACT
| |
Context Guillain-Barré syndrome (GBS) is the foremost cause of acute,
generalized, peripheral neuropathic weakness. Although nerve conduction studies
are a diagnostic aid, the characteristic electrical changes may not evolve
for several weeks. Early diagnosis of GBS is important, however, because early
treatment has been shown to improve outcome.
Objectives To describe the electrodiagnostic abnormalities detectable in the first
week of GBS, to determine if there are early patterns suggestive of GBS, and
to identify the percentage of patients whose condition can be diagnosed with
reasonable certainty in the first week.
Design and Setting We retrospectively reviewed the medical records of all patients admitted
to the Cleveland Clinic Foundation, Cleveland, Ohio, having the discharge
diagnosis GBS during the past 16 years. Patients who underwent nerve conduction
studies within 7 days of muscle weakness were selected for this study.
Results The H reflex was absent in 30 (97%) of 31 patients. Nineteen patients
(61%) had low-amplitude or absent sensory nerve action potential (SNAP) in
the upper extremity. Fifteen patients (48%) overall, including 21 (67%) of
the 31 patients, including 14 (67%) of the 21 patients younger than 60 years,
had an abnormal upper extremity SNAP combined with a normal sural SNAP. Other
findings included an abnormal F wave (25 patients [84%]), reduced compound
muscle action potential amplitude (22 patients [71%]), prolonged distal latency
(20 patients [65%]), temporal dispersion (18 patients [58%]), slowed motor
conduction velocity (16 patients [52%]), and motor conduction block (4 patients
[13%]). Definite diagnosis was possible in 17 patients (55%), but not commonly
until the fifth day.
Conclusions The H reflex is the most sensitive test for early GBS. Upper extremity
SNAPs are also frequently abnormal in early GBS. Absent H response, abnormal
F wave, and abnormal upper extremity SNAP combined with a normal sural SNAP
are characteristic of early GBS. If multiple nerves are tested, definite diagnosis
is possible in half the patients, but not until the fifth day after the onset
of symptoms.
INTRODUCTION
GUILLAIN-BARRÉ syndrome (GBS) is the most common cause of acute
and severe generalized peripheral neuropathic weakness.1
Nerve conduction studies (NCSs) are the most important ancillary diagnostic
test. Electrodiagnostic (EDX) studies often show evidence of patchy demyelination,
manifested as conduction block, slowed motor conduction velocities (CVs),
delayed latencies, and dispersed responses2;
however, axon loss variants have been described.3
While the electrical abnormalities may not be sufficiently widespread for
definite diagnosis in the first 2 weeks,2 early
diagnosis is important, because treatment shortens the course of GBS, reduces
the time required to receive mechanical respiratory assistance, and lessens
the overall severity.4, 5, 6
The goal of this study was to determine if there are characteristic EDX findings
within the first week or if there are early patterns that are suggestive of
GBS so that interventional treatment may be initiated with confidence. We
retrospectively reviewed the medical records of all patients with GBS who
underwent EDX studies at our center within the first 7 days after onset of
motor symptoms to determine the most common early electrical findings and
the percentage of patients who could be diagnosed with reasonable certainty.
PATIENTS, MATERIALS, AND METHODS
SELECTION OF PATIENTS
We retrospectively reviewed the medical records of all patients given
the clinical diagnosis of GBS during the past 16 years. Those patients who
underwent EDX testing within 7 days after the onset of motor symptoms were
selected for this study. Patients were included if findings from the clinical,
radiographic imaging, laboratory, and EDX studies combined were suggestive
of GBS and not another disorder. Inclusionary criteria for the clinical diagnosis
of GBS were rapidly progressive limb weakness with or without distal limb
paresthesias and reduced deep tendon reflexes. One patient with ataxia, ophthalmoplegia,
and areflexia was diagnosed as having the Miller-Fisher syndrome. Patients
with autonomic instability and respiratory failure in addition to the aforementioned
symptoms were also included in this study. Excluded from the study were patients
with other causes of nerve conduction abnormalities (eg, renal failure or
diabetes mellitus) and patients with evidence of another neuromuscular diagnosis
(eg, myelopathy, familial polyneuropathy, multiple mononeuropathies, or chronic
peripheral polyneuropathy).
LABORATORY STUDIES
Serum chemistry levels, complete blood cell count, and heavy metal screening
results were recorded. In addition, most patients underwent lumbar puncture
and analysis of cerebrospinal fluid. Twenty-seven patients (87%) had their
cerebrospinal fluid studied within the first week after the onset of motor
symptoms.
EDX STUDIES
Motor NCS were performed in an ipsilateral upper extremity (UE) and
lower extremity (LE) using surface electrodes. Skin temperature was above
32°C in all patients. When abnormal results were obtained, often some
motor NCSs were performed in the contralateral limb for comparison. Sensory
NCSs were performed, using antidromic techniques, on the median nerve, ulnar
nerve, superficial radial nerve, and sural nerve. Motor NCSs included stimulation
of the median and ulnar nerves at the wrist and forearm while recording from
the abductor pollicis brevis muscle and abductor digiti minimi muscle of the
hand, respectively, and of the deep peroneal and posterior tibial nerves at
the ankle and knee, while recording from the extensor digitorum brevis muscle
and the abductor hallicus muscle, respectively. Supraclavicular stimulation
was performed on one or more UE motor nerves, usually the ulnar nerve, in
an attempt to identify conduction block or slowing proximal to the elbow.
F waves were measured with each motor NCS for which a compound muscle action
potential (CMAP) result was obtained. The H reflex was recorded from the gastrocnemius
and soleus muscles after stimulation of the posterior tibial nerve. The CMAP
amplitude, distal motor latency, motor nerve CVs, sensory nerve amplitude
and peak latency, H reflex amplitude and latency, and shortest F response
latencies were measured. A value was defined as abnormal if it fell outside
the laboratory's range of normal responses, which were corrected for age.
Patients were classified as having polyradiculoneuropathy consistent with
GBS if there was a combination prolonged distal motor latency (>150% of the
upper limit of normal), CV slowing (<70% of the lower limit of normal),
prolongation of F wave latency (>150% of the upper limit of normal), low CMAP
amplitude or proximal CMAP drop suggestive of conduction block, or abnormal
temporal dispersion in 2 or more nerves.7 Needle
electrode examination (NEE) was performed in only some of the patients because
of the proximity between the time EDX studies were performed and the point
of symptom onset. In those patients in whom an NEE was performed, multiple
muscles in the UE and LE were recorded.
RESULTS
CLINICAL DATA
Of the 31 patients (20 males and 11 females) who ranged in age between
4 and 76 years (mean age, 50 years), 21 were younger than 60 years (Table 1). Twenty-two patients (71%) had
an infection or surgery in the prior month. At hospital admission, all had
motor weakness; 29 (94%), loss of deep tendon reflexes; 1 (0.3%), reflexes
present only with reinforcement; and 3 (10%), acute sensory loss. One patient
was diagnosed as having Miller-Fisher syndrome by clinical examination. The
muscle weakness present, as judged by the admitting neurologist, was considered
mild in 18 (58%), moderate in 9 (29%), and severe in 4 patients (13%). However,
12 patients (39%) eventually required mechanical ventilatory assistance. The
findings of cerebrospinal fluid analysis were abnormal in 20 (71%) of 28 patients
tested, while showing the classic albuminocytologic dissociation in 18 patients
(64%), 17 of whom were studied in the first week after the onset of symptoms.
|
|
|
|
Table 1. Clinical Features in 31 Patients With Guillain-Barré
Syndrome
|
|
|
EDX DATA
H Waves
The H reflex was absent in 30 (97%) of 31 patients (Table 2). It was of low amplitude in the single remaining patient,
and it was absent in all 21 patients younger than 60 years. It was absent
in the only patient with Miller-Fisher syndrome. The EDX study findings were
completely normal, with the exception of absent H waves in 5 patients (16%).
|
|
|
|
Table 2. Electodiagnostic Findings in Patients With Guillian-Barré
Syndrome for 1 Week*
|
|
|
F Waves
Some abnormality of F waves (prolonged latency or absent response) was
detected in 26 patients (84%). The UEF waves were absent in 1 or more nerves
in 17 patients (55%), of prolonged latency in 6 patients (19%), and normal
in 8 patients (26%). The LEF waves were absent in 1 or more nerves in 19 patients
(61%), of prolonged latency in 4 patients (13%), and normal in 8 patients
(26%). While most patients had absent F waves, none met strict criteria for
demyelination with latency prolongation greater than 150% of the upper limit
of normal. Eighteen patients (58%) had at least 1 motor nerve with a normal
F wave response. Six patients (19%) had only a single abnormal F wave. Five
patients (16%) had completely normal F wave findings of at least 2 nerves
in each limb. No patient had only abnormal F waves without other NCS abnormalities.
Sensory Nerve Action Potentials
One or more SNAPs were absent in the UE in 12 patients (39%), of low
amplitude in 6 patients (19%), and delayed in 1 patient (ulnar nerve). Overall,
19 patients (61%) had 1 or more abnormal UE SNAPs. The abnormalities affected
all nerves in the UE without predilection for a single nerve. The sural SNAP
was normal in 26 patients (84%), including 19 (90%) of 21 patients younger
than 60 years in whom this response is routinely seen. The combination responses
of an absent UE SNAP and a normal sural SNAP were seen in 9 patients (29%),
8 (38%) of whom were younger than 60 years. There was a combined response
of an absent or low-amplitude UE SNAP and a normal sural SNAP in 19 (67%)
of the 31 patients younger than 60 years. Viewed from a different perspective,
in patients with a normal sural response, 15 (58%) had an abnormal SNAP in
the UE, including 14 (74%) younger than 60 years, who had reduced amplitude
(n = 2 patients), delayed latency (n = 1 patient), unelicitable response (n
= 1 patient), or some combination thereof (n = 10 patients).
Motor NCS
Abnormalities of CMAP involved both the UE and LE, often in combination,
without predilection for a particular nerve. Twenty-two patients (71%) had
reduced CMAP amplitude of at least 1 nerve with distal stimulation. The amplitude
was reduced in only 1 nerve in 3 patients and in more than 1 nerve in 19 (61%).
Responses were absent in 1 or more nerves in 2 patients. Five patients were
shown to have significant axon loss on follow-up NEE.
Distal Latency
The distal latency (DL) was prolonged in at least 1 nerve in 20 patients
(65%), in just 1 nerve in 6 patients (19%), and in multiple nerves in 14 patients
(45%). Thirteen (65%) of the 20 patients had DLs exceeding 150% of the upper
limit of normal. The prolongation was detected in the UE and LE equally.
Conduction Velocity
Slowed motor CV was found in 16 patients (52%). However, only 5 patients
(16%) had slowing of less than 70% of the laboratory's lower limit of normal,
which is generally considered to be the range for demyelination. This was
found most often on deep peroneal assessment (14 patients), followed by the
median and ulnar nerves (2 patients each), and the posterior tibial nerve
(1 patient).
Conduction Block or Temporal Dispersion
Proximal or midlimb stimulation demonstrated proximal conduction block
in 4 patients (13%). Three patients had 1 nerve involved; 1 patient had conduction
block in both the proximal ulnar and peroneal nerves. Dispersal of the CMAP,
perhaps the most specific finding in early GBS, was seen after proximal stimulation
in 1 nerve of 3 patients (10%) and in multiple nerves in 15 patients (48%).
Overall, 18 patients (58%) had CMAP dispersion in at least 1 nerve.
ELECTROMYOGRAPHIC FINDINGS
Needle electrode examination was performed in only 6 patients because
of the proximity of EDX assessment to symptom onset. Motor unit potential
number and recruitment was reduced in all patients. One patient had fibrillation
potentials in proximal UE and LE muscles on initial NEE just 5 days after
the onset of motor symptoms.
Definite diagnosis of GBS was possible because of some combination of
motor CV slowing, reduction of CMAP amplitudes, abnormal dispersion, conduction
block, or prolongation of minimum F wave latency in 2 or more nerves in 17
patients (55%). The H reflex was the only frequently abnormal finding from
the onset of symptoms. The constellation of findings necessary for definite
diagnosis was not commonly seen until the fifth day (Table 3).
|
|
|
|
Table 3. Evolution of Nerve Conductive Study (NCS) Changes*
|
|
|
COMMENT
To our knowledge, no EDX trial has been concerned solely with patients
whose GBS symptoms were of 1 week or less. The purpose of this study was to
identify the most common early EDX abnormalities found with GBS. Diagnosis
within the first week is often difficult because the elevation of the cerebrospinal
fluid protein level and motor NCS changes may not evolve until later, yet
early diagnosis is desired, since several treatments have been shown to lessen
the disease severity and improve outcome.4, 5, 6
We assessed 31 patients who underwent EDX testing within 7 days of onset of
motor weakness. We identified the earliest EDX changes and the percentage
of patients whose diagnosis could be made with certainty. Definite diagnosis
was based on a constellation of findings including slowed motor CV, delayed
latencies, dispersion of responses and conduction block, low distal CMAP amplitudes,
and prolongation of minimum F wave latency.7
We chose the timing of disease onset to be the appearance of clinical weakness
because that symptom is most readily identifiable. Motor symptoms may not
definitely represent commencement of disease in all patients, however.
Electrodiagnostic studies have been used in the diagnosis of GBS for
almost 50 years.8 Initial EDX investigations
showed multifocal demyelination to be a common underlying pathophysiologic
condition.9, 10, 11, 12
Large studies have included patients with symptoms for less than 1 week,13, 14 although H reflexes and sensory NCS
abnormalities in this group specifically were not commented on. In the report
by Ropper et al,13 41 patients underwent EDX
studies within 1 week of symptom onset. Sixteen of these patients had multiple
abnormalities of CMAPs, including dispersion, delayed latency, low amplitude,
CV slowing, conduction block, or abnormal F waves. Only 5 of these patients,
however, had CV slowing of less than 80% of the lower limit of normal in at
least 2 nerves. Fifteen had some abnormality of F wave. Clouston et al14 assessed the CMAP in 47 patients with GBS, 20 of
whom were evaluated less than 1 week from symptom onset. Thirteen had at least
1 nerve with low-amplitude CMAP; in 10 of these patients the CMAP amplitude
fell with proximal stimulation suggesting conduction block. Those patients
with low-amplitude CMAPs had a poorer outcome.
An axon loss variant of GBS, termed "acute axonal motor neuropathy"
or "acute motor and sensory axonal neuropathy" occurs in 11% of these patients
and is associated with slower recovery.15 Occasionally,
primary demyelination with secondary axonal damage will mimic clinically and
electrophysiologically the axonal variant of GBS,15
however. In addition, a syndrome of rapidly progressive and severe but reversible
weakness with low CMAP amplitude has been identified in Chinese children.16, 17 The reduced CMAP amplitude in some
of these children represents severe distal demyelination with variable axon
loss. Hence, severe reduction in CMAP amplitude early in the course of GBS
may be caused by distal demyelination, axon loss, or both, and so inexactly
reflects prognosis.15, 18 Five
of the 20 patients in our study with low CMAP amplitudes had significant evidence
of acute denervation on follow-up NEE. Three of these patients were nonambulatory
at follow-up. The remaining 15 patients with reduced CMAP amplitudes may have
had distal conduction block, although there was no definite proof.
Diagnostic criteria for the early detection of GBS, when EDX changes
are not yet fully apparent, have been proposed but have focused largely on
motor NCS and have not included the H reflex or the comparison of the results
of the different sensory studies.7 The H reflex
is a sensitive objective test for detecting subtle abnormalities of the S1
nerve root and for detecting early polyneuropathy. While correlation with
presence of the Achilles reflex is high, it is not absolute and interexaminer
variability has been reported in testing the ankle jerk.19, 20
Our data show that the H reflex test is the most sensitive test for early
GBS. The H reflex was absent or abnormal in all of our patients from symptom
onset (Table 2), including all
21 patients younger than 60 years in whom it is normally obtainable. It was
abnormal earlier and more often than other procedures, which were not commonly
abnormal until day 5 and it was the sole abnormality in 5 (16%) of our 31
patients. It was unobtainable in the patient who had Miller-Fisher syndrome.
In this regard, the H reflex test was more sensitive than F wave studies.
Eighteen (58%) of our 31 patients had at least 1 normal F wave study, and
often multiple nerves had to be tested to detect F wave abnormality. Our experience
suggests that H reflex assessment should become part of the standard repertoire
in the early diagnosis of GBS. Nevertheless, unobtainable H waves, similar
to unobtainable F waves, are nonspecific and nondiagnostic by themselves because
they are not conclusive evidence of demyelination.
Sensory nerve action potentials are also frequently abnormal in early
GBS.21, 22 Vague sensory symptoms
precede motor weakness by hours to weeks in many cases. We identified the
unusual combination of normal SNAPs in the LE (usually the sural nerve) and
low-amplitude or absent SNAPs in the UE in almost half of our 31 patients.
This percentage increased to two thirds in our patients younger than 60 years,
in whom a sural SNAP would normally be present. Although there is nothing
abnormal about a normal sural NCS response, and nothing diagnostic regarding
a low-amplitude UE SNAP, this combination of changes should be considered
indicative of an acquired demyelination disorder, especially when seen with
an absent H reflex. These findings together are almost never seen in other
polyneuropathies, except chronic inflammatory demyelinating polyneuropathy,
or with other disorders that mimic GBS.
Finally, our data show that findings sufficient for diagnosis are more
common after the fourth day from motor symptom onset (Table 3), are not necessarily suggestive of demyelination unless
combined, and, as others have reported,23 are
more likely to be discovered if multiple nerves are studied. While study findings
other than the H reflex were frequently abnormal, including F waves (26 patients
[84%]), CMAP amplitude (22 patients [71%]), DL (20 patients [65%]), motor
CV (16 patients [52%]), or waveform (18 patients [58%]), these findings were
patchy and were not commonly present until after the fourth day. There was
no tendency for these abnormalities to occur in a specific nerve. Unlike the
H wave, often multiple nerves had to be tested to detect a single abnormality
and most patients had 1 or more normal F waves. Only 5 patients had motor
CV slowing in our laboratory's demyelinating range, thus, when present, motor
CV slowing found within the first week was usually mild. This finding is worth
emphasizing because significant CV slowing is often considered to be a hallmark
of early GBS. Electrodiagnostic studies performed before the fifth day were
likely to be nondiagnostic. In the patients for whom no definite EDX diagnosis
was possible and in patients with symptoms of less than 4 days, the findings
were usually nonspecific and not necessarily suggestive of demyelination even
when combined.
The diagnosis of GBS within the first week of motor onset is difficult,
and in this sense, EDX studies are least helpful when they are most important.
Certain EDX findings, especially absent H reflexes, abnormal F waves, and
the combination of abnormal UE SNAP and a normal sural SNAP, while not suggestive
of demyelination by themselves, are characteristic of acquired demyelinating
polyradiculoneuropathies when they occur together. A constellation of abnormalities
sufficient for definite diagnosis is more common after the fourth day from
onset of motor weakness, is present in half of the patients, and is more easily
detected if multiple nerves in several limbs are studied.
AUTHOR INFORMATION
Accepted for publication January 1, 2001.
From the Departments of Neurology, University of New Mexico School
of Medicine, Albuquerque (Dr Gordon); and the Cleveland Clinic Foundation,
Cleveland, Ohio (Dr Wilbourn).
Corresponding author: Paul H. Gordon, MD, Department of Neurology,
University of New Mexico School of Medicine, 915 Camino de Salud NE, Albuquerque,
NM 87131 (e-mail: pgordon{at}salud.unm.edu).
REFERENCES
| |
1. Weinberg DH for the American Association of Electrodiagnostic Medicine. AAEM case report 4: Guillain-Barré syndrome. Muscle Nerve. 1999;22:271-281.
PUBMED
2. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and
electrodiagnostic features. Muscle Nerve. 1989;12:435-451.
FULL TEXT
|
ISI
| PUBMED
3. Jacobs BC, Meulstee J, van Doorn PA, van der Meche FG. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies
in Guillain-Barré syndrome. Muscle Nerve. 1997;20:446-452.
FULL TEXT
|
ISI
| PUBMED
4. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology. 1985;35:1096-1104.
FREE FULL TEXT
5. French Cooperative Group on Plasma Exchange in Guillain-Barré
Syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role
of replacement fluids. Ann Neurol. 1987;22:753-761.
FULL TEXT
|
ISI
| PUBMED
6. van der Meche FG, Schmitz PIM for the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma
exchange in Guillain-Barré syndrome. N Engl J Med. 1992;326:1123-1129.
ABSTRACT
7. Meulstee J, van der Meche FG for the Dutch Guillain-Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application
in 135 patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1995;59:482-486.
ABSTRACT
8. Hendriksen JD. The Conduction Velocity of Motor Nerves in Normal
Subjects and in Patients With Neuromuscular Disorders [master's thesis]. Cleveland, Ohio: Mayo Foundation; 1956.
9. Bannister RG, Sears TA. The changes in nerve conduction in acute idiopathic polyneuritis. J Neurol Neurosurg Psychiatry. 1962;25:321-328.
10. Lambert EH, Mulder DW. Nerve conduction in the Guillain-Barré syndrome [abstract]. Electroenceph Clin Neurophysiol. 1964;17:86.
11. Eisen A, Humphreys P. The Guillain-Barré syndrome: a clinical and electrodiagnostic
study of 25 cases. Arch Neurol. 1974;30:438-443.
PUBMED
12. Brown WF, Snow R. Patterns and severity of conduction abnormalities in Guillain-Barré
syndrome. J Neurol Neurosurg Psychiatry. 1991;54:768-774.
ABSTRACT
13. Ropper AH, Wijdicks EFM, Shahani T. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré
syndrome. Arch Neurol. 1990;47:881-887.
ABSTRACT
14. Clouston PD, Kiers L, Zuniga G, Cros D. Quantitative analysis of the compound muscle action potential in early
acute inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol. 1994;93:245-254.
PUBMED
15. Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute "axonal" form of Guillain-Barré
syndrome. Muscle Nerve. 1993;16:200-205.
FULL TEXT
|
ISI
| PUBMED
16. McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease
of children and young adults in northern China. Lancet. 1991;338:593-597.
FULL TEXT
|
ISI
| PUBMED
17. Massaro ME, Rodriquez EC, Pociecha J, et al. Nerve biopsy in children with severe Guillain-Barré syndrome
and unexcitable motor nerves. Neurology. 1998;51:394-398.
FREE FULL TEXT
18. Zhang X, Tang X, Zhang Z, Du H, Li B. Electrophysiological forms of Guillain-Barré syndrome in Beijing
suburb. Chin Med J (Engl). 1997;110:856-858.
PUBMED
19. Katirji B, Weissman JD. The ankle jerk and the tibial H-reflex: a clinical and electrophysiological
correlation. Electromyogr Clin Neurophysiol. 1994;34:331-334.
PUBMED
20. O'Keeffe ST, Smith T, Valacio R, Jack CI, Playfer JR, Lye M. A comparison of two techniques for ankle jerk assessment in elderly
subjects. Lancet. 1994;344:1619-1620.
PUBMED
21. Sorensen R, Wilbourn A. Sequential electromyographic changes in Guillain-Barré syndrome. Muscle Nerve. 1985;8:626.
22. Murray NM, Wade DT. The sural sensory action potential in Guillain-Barré syndrome
[abstract]. Muscle Nerve. 1980;3:444.
23. McLeod JG, Walsh JC, Prineas JW, Pollard JD. Acute idiopathic polyneuritis: a clinical and electrophysiological
follow-up study. J Neurol Sci. 1976;27:145-162.
FULL TEXT
| PUBMED
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(6):1028-1029.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
CSF neurofilament levels: A potential prognostic marker in Guillain-Barre syndrome.
Petzold et al.
Neurology 2006;67:1071-1073.
ABSTRACT
| FULL TEXT
Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery
Uncini et al.
Neurology 2006;67:543-543.
FULL TEXT
A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks
Lefaucheur et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1555-1561.
ABSTRACT
| FULL TEXT
Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant
Capasso et al.
Neurology 2003;61:617-622.
ABSTRACT
| FULL TEXT
MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barre syndrome
Sharshar et al.
Neurology 2002;59:1649-1651.
ABSTRACT
| FULL TEXT
|
